Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.
Stem Cell Reports
; 16(7): 1652-1655, 2021 07 13.
Article
em En
| MEDLINE
| ID: mdl-34214486
Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pesquisa Translacional Biomédica
/
Epigenômica
/
Edição de Genes
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Stem Cell Reports
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Austrália